 | Up a level |
Drilon, Alexander, Siena, Salvatore, Dziadziuszko, Rafal 
ORCID: 0000-0001-8080-9843, Barlesi, Fabrice, Krebs, Matthew G., Shaw, Alice T., de Braud, Filippo, Rolfo, Christian, Ahn, Myung-Ju, Wolf, Juergen, Seto, Takashi, Cho, Byoung Chul, Patel, Manish R., Chiu, Chao-Hua, John, Thomas, Goto, Koichi, Karapetis, Christos S., Arkenau, Hendrick-Tobias, Kim, Sang-We, Ohe, Yuichiro, Li, Yu-Chung, Chae, Young K., Chung, Christine H., Otterson, Gregory A., Murakami, Haruyasu, Lin, Chia-Chi, Tan, Daniel S. W., Prenen, Hans, Riehl, Todd, Chow-Maneval, Edna, Simmons, Brian, Cui, Na, Johnson, Ann, Eng, Susan, Wilson, Timothy R. and Doebele, Robert C.
(2020).
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Lancet Oncol., 21 (2).
S. 261 - 271.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Thress, Kenneth, Leeson, James, Geradts, Joseph, Schuler, Martin, Ahn, Myung-Ju, Wolf, Juergen, Gold, Kathryn A., Yang, James Chih-Hsin, Blackhall, Fiona, Su, Wu-Chou, Jacobs, Vivien, Smith, Neil R., Angell, Helen, Brown, Kathryn, Vishwanathan, Karthick, Barrett, J. Carl, Cantarini, Mireille and Jaenne, Pasi A. (2015). Design, Execution, and Preliminary Biomarker Results from Paired Tumor Biopsy Cohorts of the AZD9291 AURA Trial. J. Thorac. Oncol., 10 (9). S. S320 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380